Can axillary radiotherapy replace axillary dissection for patients with positive sentinel nodes? A systematic review and meta-analysis

Objective To compare the efficacy of axillary radiotherapy (ART) with that of completion axillary lymph node dissection (cALND) in clinically node‐negative breast cancer patients with a positive sentinel lymph node. Methods A literature search was performed in PubMed, EMBASE and Cochrane Library by using the search terms “breast cancer”, “sentinel lymph node biopsy”, “axillary radiotherapy” or “regional node irradiation” for articles published between 2004 and 2016. Only randomized controlled trials that included patients with positive sentinel nodes were included in the meta‐analysis. Results Two randomized controlled trials and three retrospective studies were identified. The reported overall survival rate (hazard ratio [ HR ] = 1.09, 95% confidence interval [ CI ]: 0.75–1.43, P = 0.365), disease‐free survival rate ( HR = 1.01, 95% CI : 0.58–1.45, P = 0.144), and axillary recurrence rate (1.2% and 0.4%, and 1.3% and 0.8%, respectively) were similar in both groups. The absence of knowledge on the extent of nodal involvement in the ART group appeared to have no major impact on the administration of adjuvant systemic therapy. Conclusions ART is not inferior to cALND in the patients with clinically node‐negative breast cancer who had a positive sentinel lymph node. Information obtained by using cALND after SLNB may have no major impact on the administration of adjuvant systemic therapy.

Abstract licence: CC BY-NC-ND

1. 19.

   Practical methods for incorporating summary time-to-event data into meta-analysis · 2007

2. 26.

   CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials · 2010

46 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.